Patent · US Active

N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

US9969745B2 · kind B2 · utility

1Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2017
Grant dateMay 15, 2018
Priority date—
Expiry dateNov 9, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel compounds of Formula Imethods of manufacturing the compounds and their use in therapeutic treatments are presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.